Literature DB >> 20873705

Laboratory measurement of the absorption coefficient of riboflavin for ultraviolet light (365 nm).

Hans Peter Iseli1, Max Popp, Theo Seiler, Eberhard Spoerl, Michael Mrochen.   

Abstract

PURPOSE: Corneal cross-linking (CXL) is an increasingly used treatment technique for stabilizing the cornea in keratoconus. Cross-linking (polymerization) between collagen fibrils is induced by riboflavin (vitamin B2) and ultraviolet light (365 nm). Although reported to reach a constant value at higher riboflavin concentrations, the Lambert-Beer law predicts a linear increase in the absorption coefficient. This work was carried out to determine absorption behavior at different riboflavin concentrations and to further investigate the purported plateau absorption coefficient value of riboflavin and to identify possible bleaching effects.
METHODS: The Lambert-Beer law was used to calculate the absorption coefficient at various riboflavin concentrations. The following investigated concentrations of riboflavin solutions were prepared using a mixture of 0.5% riboflavin and 20% Dextran T500 dissolved in 0.9% sodium chloride solution: 0%, 0.02%, 0.03%, 0.04%, 0.05%, 0.06%, 0.08%, 0.1%, 0.2%, 0.3%, 0.4%, and 0.5%, and were investigated with and without aperture plate implementation. An additional test series measured the transmitted power at selected riboflavin concentrations over time.
RESULTS: In diluted solutions, a linear correlation exists between the absorption coefficient and riboflavin concentration. The absorption coefficient reaches a plateau, but this occurs at a higher riboflavin concentration (0.1%) than previously reported (just above 0.04%). Transmitted light power increases over time, indicating a bleaching effect of riboflavin.
CONCLUSIONS: The riboflavin concentration can be effectively varied as a treatment parameter in a considerably broader range than previously thought. Copyright 2011, SLACK Incorporated.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20873705     DOI: 10.3928/1081597X-20100604-01

Source DB:  PubMed          Journal:  J Refract Surg        ISSN: 1081-597X            Impact factor:   3.573


  9 in total

1.  Effect of the synthetic NC-1059 peptide on diffusion of riboflavin across an intact corneal epithelium.

Authors:  Yuntao Zhang; Pinakin Sukthankar; John M Tomich; Gary W Conrad
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-05-04       Impact factor: 4.799

2.  Light Absorptive Properties of Articular Cartilage, ECM Molecules, Synovial Fluid, and Photoinitiators as Potential Barriers to Light-Initiated Polymer Scaffolding Procedures.

Authors:  Anthony J Finch; Jamie M Benson; Patrick E Donnelly; Peter A Torzilli
Journal:  Cartilage       Date:  2017-06-18       Impact factor: 4.634

Review 3.  Current perspectives on corneal collagen crosslinking (CXL).

Authors:  Sandeepani K Subasinghe; Kelechi C Ogbuehi; George J Dias
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-04-06       Impact factor: 3.117

4.  Riboflavin concentration in corneal stroma after intracameral injection.

Authors:  Na Li; Xiu-Jun Peng; Zheng-Jun Fan; Xu Pang; Yu Xia; Teng-Fei Wu
Journal:  Int J Ophthalmol       Date:  2015-06-18       Impact factor: 1.779

5.  Comparison between standard and transepithelial corneal crosslinking using a theranostic UV-A device.

Authors:  Giuseppe Lombardo; Sebastiano Serrao; Marco Lombardo
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-01-03       Impact factor: 3.117

6.  Corneal Haze and Densitometry in Keratoconus after Collagen Cross-Linking by Three Different Protocols.

Authors:  Amani E Badawi
Journal:  J Curr Ophthalmol       Date:  2022-01-06

Review 7.  Corneal collagen cross-linking (CXL) in thin corneas.

Authors:  Xiangjun Chen; Aleksandar Stojanovic; Jon Roger Eidet; Tor Paaske Utheim
Journal:  Eye Vis (Lond)       Date:  2015-09-07

8.  Corneal collagen cross-linking with and without epithelial removal: a contralateral study with 0.5% hypotonic riboflavin solution.

Authors:  Aleksandar Stojanovic; Wen Zhou; Tor Paaske Utheim
Journal:  Biomed Res Int       Date:  2014-06-22       Impact factor: 3.411

Review 9.  Corneal Cross-Linking: The Evolution of Treatment for Corneal Diseases.

Authors:  Duoduo Wu; Dawn Ka-Ann Lim; Blanche Xiao Hong Lim; Nathan Wong; Farhad Hafezi; Ray Manotosh; Chris Hong Long Lim
Journal:  Front Pharmacol       Date:  2021-07-19       Impact factor: 5.810

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.